HOME >> MEDICINE >> NEWS
ARICEPT better tolerated than Exelon in patients with mild to moderate Alzheimers disease

First head-to-head study of ARICEPT (donepezil hydrochloride) and Exelon (rivastigmine tartrate) offers comparative information of clinical use to physicians

Study patients treated according to approved product labeling

NEW YORK, SEPTEMBER 27, 2000 - Results from the first head-to-head study between ARICEPT (donepezil hydrochloride) (Eisai and Pfizer Inc) and Exelon (rivastigmine tartrate) (Novartis Pharma AG) showed that in this open-label study ARICEPT was better tolerated than Exelon in patients with mild to moderate Alzheimers disease. Data were presented at a scientific conference earlier this month in Munich, Germany.

"Despite the often devastating nature of the disease, tolerability is still very important to patients with Alzheimer's disease," said David Wilkinson, MD, director of the Memory Assessment and Research Centre, Moorgreen Hospital, Southampton, England, and an investigator in the study. Patients tend to be elderly and often have other medical conditions that can make treating Alzheimers disease more complex. It is therefore important to treat patients with medications that are well tolerated and easy to use, such as ARICEPT.

The multinational, head-to-head, open-label study was designed to compare the tolerability and ease of use of ARICEPT to Exelon in 111 patients with mild to moderate Alzheimers disease.

The two treatment groups had similar improvements from baseline in Alzheimers Disease Assessment Scale-cognitive subscale (ADAS-cog) scores throughout the 12-week treatment period. ADAS-cog is a clinically validated measure of cognitive function. Testing was administered by independent raters who were blinded to study medication.

Key study findings:

  • Almost 4 times as many patients in the Exelon (rivastigmine tartrate)-treatment group reported nausea compared with the ARICEPT (donepezil hydrochloride)-treatment group (41.8% vs 10.7%). '"/>


Contact: Celeste Torello, Pfizer Inc.
212-733-6471
Porter Novelli
26-Sep-2000


Page: 1 2 3 4

Related medicine news :

1. ARICEPT significantly improves cognition, daily living over Reminyl in Alzheimers patients
2. First-of-its-kind study of vascular dementia patients taking ARICEPT presented at AAGP meeting
3. Vascular dementia patients taking ARICEPT show significant treatment benefits in cognition and function
4. Do minorities survive hospitalization better than others?
5. Boston University team finds link between high cholesterol and better cognitive performance
6. Specialist care gives better rate of survival
7. Balance and better interactions between primary-care and specialist physicians improve US health
8. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
9. Pet scanning better for heart disease diagnosis, management
10. Laughter helps blood vessels function better
11. MRI better than current standard in assessing neoadjuvant chemotherapy for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... ScripHessco has announced the release ... guide breaks down the benefits of chiropractic care during pregnancy and how to ... is quite beneficial to the mother’s health. Seeing a chiropractor during pregnancy leads ...
(Date:2/13/2020)... ... February 13, 2020 , ... ... sectors, committed to achieving health equity for all Americans will unveil its new ... February 26th event at the National Press Club. , The event will feature ...
(Date:2/13/2020)... ... , ... A January 24 article from Refinery29 looks at trends ... also reports on a well-documented dramatic and ongoing increase over the last 20 years ... increasingly knowledgeable and are asking about a number of both traditional plastic surgeries and ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... North America, is pleased to announce a $5,000 grant to provide free dental ... (DSG) has generously donated to the Smiles for Everyone Foundation , which ...
(Date:2/10/2020)... (PRWEB) , ... February 10, 2020 , ... ... named vice president in the company’s healthcare division. In this role, Nikki will ... as guide the company’s continued healthcare product development. , “The healthcare industry ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... ... February 14, 2020 , ... Dr. Ray Lopez, renowned foot and ankle ... The Haute Beauty Network, well known for its exclusive and luxurious lifestyle publication Haute ... our newest addition to the Haute Beauty members-only network. , Haute Beauty offers a ...
(Date:2/14/2020)... ... February 14, 2020 , ... American ... Commerce beginning fall semester 2020, the first of its kind in this region. ... a career in the cannabis industry and will provide students with an understanding ...
(Date:2/14/2020)... ... , ... The Jim Ellis Automotive Group is proud to ... their annual Holiday Giving Campaign. The fundraiser has been a long-standing holiday tradition ... 29, 2019, through January 2, 2020, are donated to a deserving organization. ...
Breaking Medicine Technology:
Cached News: